🇺🇸 FDA
Patent

US 9950076

Maytansinoid derivatives, conjugates thereof, and methods of use

granted A61KA61K31/537A61K47/68

Quick answer

US patent 9950076 (Maytansinoid derivatives, conjugates thereof, and methods of use) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
53
CPC classes
A61K, A61K31/537, A61K47/68, A61K47/6851, A61P